U.S. markets closed

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
143.53-0.59 (-0.41%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 8/9/2020
Current
6/30/20203/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
16.55B17.01B12.32B12.92B8.95B7.73B
Enterprise Value 3
15.51B15.97B11.09B11.50B7.36B6.82B
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
56.0057.5554.1272.5982.6985.71
Price/Book (mrq)
12.2612.608.568.045.095.21
Enterprise Value/Revenue 3
44.93153.60111.44160.49105.09152.41
Enterprise Value/EBITDA 6
-19.17-120.17-57.40-40.61-37.06-30.09

Trading Information

Stock Price History

Beta (5Y Monthly) 1.80
52-Week Change 381.96%
S&P500 52-Week Change 316.25%
52 Week High 3167.33
52 Week Low 373.32
50-Day Moving Average 3153.75
200-Day Moving Average 3131.61

Share Statistics

Avg Vol (3 month) 3759.78k
Avg Vol (10 day) 3459.63k
Shares Outstanding 5114.82M
Float 114.99M
% Held by Insiders 10.80%
% Held by Institutions 194.74%
Shares Short (Jul 14, 2020) 44.73M
Short Ratio (Jul 14, 2020) 44.73
Short % of Float (Jul 14, 2020) 45.70%
Short % of Shares Outstanding (Jul 14, 2020) 44.12%
Shares Short (prior month Jun 14, 2020) 45.85M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin -245.14%
Operating Margin (ttm)-267.51%

Management Effectiveness

Return on Assets (ttm)-18.95%
Return on Equity (ttm)-53.61%

Income Statement

Revenue (ttm)345.18M
Revenue Per Share (ttm)3.06
Quarterly Revenue Growth (yoy)132.50%
Gross Profit (ttm)194.69M
EBITDA -898.09M
Net Income Avi to Common (ttm)-846.17M
Diluted EPS (ttm)-7.51
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.93B
Total Cash Per Share (mrq)16.6
Total Debt (mrq)315.06M
Total Debt/Equity (mrq)22.51
Current Ratio (mrq)5.62
Book Value Per Share (mrq)12.10

Cash Flow Statement

Operating Cash Flow (ttm)-760.1M
Levered Free Cash Flow (ttm)-508.22M